Skip to main content
SpringerLink
Log in

Current Treatment Options: Vestibular Migraine

  • Neurologic Ophthalmology and Otology (RK Shin and DR Gold, Section Editors)
  • Published:
  • volume 19, Article number: 38 (2017)
Current Treatment Options in Neurology Aims and scope Submit manuscript

Cite this article

Opinion statement

Vestibular migraine (VM) is a disorder with a spectrum of clinical presentations and among the most common causes of chronic vestibular symptoms. Some present with attacks before or during typical migraine, but many others have fluctuating or daily symptoms. While the symptoms and pathogenesis of vestibular migraine may have elements of both central and peripheral disorders, hearing loss should be absent. VM typically worsens with activity and head movements in general, and encompasses symptoms of vertigo, disequilibrium, or imbalance. While it is possible to confuse other disorders such as Meniere’s disease with migraine, it is worth making the diagnosis of vestibular migraine on clinical grounds after ruling out other possible causes. For acute attack treatment, migraine-specific medications such as triptans may be effective. In patients with frequent or disabling attacks, preventive treatment is essential. Vestibular rehabilitation may be helpful as well as medications used for migraine prevention such as including propranolol, venlafaxine, topiramate, and amitriptyline. For refractory patients, use of acetazolamide or lamotrigine may be reasonable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Stovner L, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.

    Article  PubMed  Google Scholar 

  2. Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307–15.

    Article  PubMed  Google Scholar 

  3. • Vukovic V, et al. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache. 2007;47(10):1427–35. This article is one of few population studies assessing prevalence of migrainous vertigo.

    Article  PubMed  Google Scholar 

  4. •• Neuhauser HK, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006;67(6):1028–33. This article is the largest population study assessing prevalence of migrainous vertigo.

    Article  CAS  PubMed  Google Scholar 

  5. Geser R, Straumann D. Referral and final diagnoses of patients assessed in an academic vertigo center. Front Neurol. 2012;3:169.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bisdorff AR, Staab JP, Newman-Toker DE. Overview of the international classification of vestibular disorders. Neurol Clin. 2015;33(3):541–50. vii

    Article  PubMed  Google Scholar 

  7. Cal R, Bahmad F Jr. Migraine associated with auditory-vestibular dysfunction. Braz J Otorhinolaryngol. 2008;74(4):606–12.

    Article  PubMed  Google Scholar 

  8. Bickerstaff ER. Impairment of consciousness in migraine. Lancet. 1961;2(7211):1057–9.

    Article  CAS  PubMed  Google Scholar 

  9. •• Headache Classification Committee of the International Headache, S. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. This publication defines the current standard for diagnosis of vestibular migraine.

    Article  Google Scholar 

  10. •• Neuhauser H, et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56(4):436–41. This article features population data analyzing features of migrainous vertigo.

    Article  CAS  PubMed  Google Scholar 

  11. Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246(10):883–92.

    Article  CAS  PubMed  Google Scholar 

  12. Chen J, et al. Clinical characteristics of 100 vestibular migraine cases. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;30(5):399–401.

    PubMed  Google Scholar 

  13. Van Ombergen A, et al. Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol. 2015;36(1):133–8.

    PubMed  Google Scholar 

  14. Langhagen T, et al. Vestibular migraine in children and adolescents: clinical findings and laboratory tests. Front Neurol. 2014;5:292.

    PubMed  Google Scholar 

  15. Qiu F, et al. An analysis of clinical features of 226 vestibular migraine patients. Zhonghua Nei Ke Za Zhi. 2014;53(12):961–3.

    PubMed  Google Scholar 

  16. Goto F, Tsutsumi T, Ogawa K. The clinical features of migraine-associated vertigo. Nihon Jibiinkoka Gakkai Kaiho. 2013;116(8):953–9.

    Article  PubMed  Google Scholar 

  17. Martinez E, et al. Clinical characteristics of vestibular migraine: considerations in a series of 41 patients. Rev Neurol. 2017;64(1):1–6.

    CAS  PubMed  Google Scholar 

  18. Neff BA, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Meniere’s disease, vestibular migraine, and Meniere’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33(7):1235–44.

    Article  PubMed  Google Scholar 

  19. Kattah JC, et al. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40(11):3504–10.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Adour KK. Otological complications of herpes zoster. Ann Neurol. 1994;35(Suppl):S62–4.

    Article  PubMed  Google Scholar 

  21. Seltzer S, McCabe BF. Perilymph fistula: the Iowa experience. Laryngoscope. 1986;96(1):37–49.

    Article  CAS  PubMed  Google Scholar 

  22. Minor LB, et al. Symptoms and signs in superior canal dehiscence syndrome. Ann N Y Acad Sci. 2001;942:259–73.

    Article  CAS  PubMed  Google Scholar 

  23. Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery. 1997;40(1):1–9. discussion 9-10

    CAS  PubMed  Google Scholar 

  24. Norrving B, Magnusson M, Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand. 1995;91(1):43–8.

    Article  CAS  PubMed  Google Scholar 

  25. Bulsara KR, Velez DA, Villavicencio A. Rotational vertebral artery insufficiency resulting from cervical spondylosis: case report and review of the literature. Surg Neurol. 2006;65(6):625–7.

    Article  PubMed  Google Scholar 

  26. Cass SP, et al. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol. 1997;106(3):182–9.

    Article  CAS  PubMed  Google Scholar 

  27. Vongvaivanich K, et al. Late-life migraine accompaniments: a narrative review. Cephalalgia. 2015;35(10):894–911.

    Article  PubMed  Google Scholar 

  28. • Sohn JH. Recent advances in the understanding of vestibular migraine. Behav Neurol. 2016;2016:1801845. This article features recent evidence for pathophysiological mechanisms in vestibular migraine.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12(7):706–15.

    Article  CAS  PubMed  Google Scholar 

  30. Balaban CD, Jacob RG, Furman JM. Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother. 2011;11(3):379–94.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Vass Z, et al. Direct evidence of trigeminal innervation of the cochlear blood vessels. Neuroscience. 1998;84(2):559–67.

    Article  CAS  PubMed  Google Scholar 

  32. von Brevern M, et al. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128(Pt 2):365–74.

    Google Scholar 

  33. Ahn SK, Balaban CD. Distribution of 5-HT1B and 5-HT1D receptors in the inner ear. Brain Res. 2010;1346:92–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Lempert T. Vestibular migraine. Semin Neurol. 2013;33(3):212–8.

    Article  PubMed  Google Scholar 

  35. Marano E, et al. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache. 2005;45(4):325–31.

    Article  PubMed  Google Scholar 

  36. Shin JH, et al. Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2014;34(1):58–67.

    Article  PubMed  Google Scholar 

  37. Russo A, et al. Abnormal thalamic function in patients with vestibular migraine. Neurology. 2014;82(23):2120–6.

    Article  PubMed  Google Scholar 

  38. Bahmad F Jr, et al. Locus for familial migrainous vertigo disease maps to chromosome 5q35. Ann Otol Rhinol Laryngol. 2009;118(9):670–6.

    Article  PubMed  PubMed Central  Google Scholar 

  39. •• Cassano D, Pizza V, Busillo V. P074. Almotriptan in the acute treatment of vestibular migraine: a retrospective study. J Headache Pain. 2015;16(Suppl 1):A114. This article is one of few studies for acute treatment of vestibular migraine.

    Article  PubMed  PubMed Central  Google Scholar 

  40. •• Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope. 2006;116(10):1782–6. This article is one of few stuides for the preventive treatment of vestibular migraine.

    Article  PubMed  Google Scholar 

  41. •• Neuhauser H, et al. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003;60(5):882–3. This article is one of few studies for acute treatment of vestibular migraine.

    Article  CAS  PubMed  Google Scholar 

  42. Celebisoy N, et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol. 2016;273(10):2947–51.

    Article  PubMed  Google Scholar 

  43. • Salmito MC, et al. Prophylactic treatment of vestibular migraine. Braz J Otorhinolaryngol. 2017;83(4):404-10. This article is one of few studies for the preventive treatment of vestibular migraine.

  44. •• Taghdiri F, et al. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Spring. 2014;3:231. This article is one of few studies for the preventive treatment of vestibular migraine.

    Article  Google Scholar 

  45. •• Teggi R, et al. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study. Neurol Sci. 2015;36(10):1869–73. This article is one of few studies for the preventive treatment of vestibular migraine.

    Article  CAS  PubMed  Google Scholar 

  46. Teive HA, et al. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism Relat Disord. 2004;10(4):243–5.

    Article  PubMed  Google Scholar 

  47. • Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb. 2004;2:103–8. This article is one of few studies for the preventive treatment of vestibular migraine.

    Google Scholar 

  48. • Waterston J. Chronic migrainous vertigo. J Clin Neurosci. 2004;11(4):384–8. This article is one of few stuides for the preventive treatment of vestibular migraine.

    Article  PubMed  Google Scholar 

  49. Morganti LO, et al. Vestibular migraine: clinical and epidemiological aspects. Braz J Otorhinolaryngol. 2016;82(4):397–402.

    Article  PubMed  Google Scholar 

  50. •• Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J Headache Pain. 2011;12(1):81–8. This article is one of few stuides for the preventive treatment of vestibular migraine.

    Article  CAS  PubMed  Google Scholar 

  51. •• Gode S, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010;50(1):77–84. This article is one of few stuides for the preventive treatment of vestibular migraine.

    Article  PubMed  Google Scholar 

  52. • Carmona S, Settecase N. Use of topiramate (topamax) in a subgroup of migraine-vertigo patients with auditory symptoms. Ann N Y Acad Sci. 2005;1039:517–20. This article is one of few stuides for the preventive treatment of vestibular migraine.

    Article  CAS  PubMed  Google Scholar 

  53. • Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol. 1997;18(3):350–4. This article is one of few studies for acute treament of vestibular migraine.

    CAS  PubMed  Google Scholar 

  54. Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn). 2015;21(4 Headache):973–89.

    Google Scholar 

  55. •• Lepcha A, et al. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271(11):2931–6. This article is one of few studies for the preventive treatment of vestibular migraine.

    Article  PubMed  Google Scholar 

  56. Brandes JL, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965–73.

    Article  CAS  PubMed  Google Scholar 

  57. Linde M, et al. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6:CD010610.

    Google Scholar 

  58. Ruiz L, Ferrandi D. Topiramate in migraine progression. J Headache Pain. 2009;10(6):419–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Dixon AK, et al. Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen). Arzneimittelforschung. 1977;27(10):1968–79.

    CAS  PubMed  Google Scholar 

  60. Vitkovic J, et al. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol. 2013;260(12):3039–48.

    Article  PubMed  Google Scholar 

  61. European Union Clinical Trials Registrar. Prophylactic treatment of vestibular migraine with metoprolol: a double-blind, placebo-controlled trial: https://www.clinicaltrialsregister.eu/ctr-search/search?query=2009-013701-34 . September 1, 2011. Accessed 1 May 2017.

  62. ClinicalTrials.gov. Verapamil vs. Sertraline for vestibular migraine & chronic subjective dizziness. https://clinicaltrials.gov/ct2/show/NCT01669304?term=vestibular+migraine&rank=3. August 14, 2012. Accessed 1 May 2017.

  63. ClinicalTrials.gov. Neuromodulation treatment of vestibular migraines. https://clinicaltrials.gov/ct2/show/NCT02866084?term=vestibular+migraine&rank=5. August 5, 2016. Accessed 1 May 2017.

  64. Radtke A, et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79(15):1607–14.

    Article  PubMed  Google Scholar 

  65. Lee JW, et al. Clinical manifestation and prognosis of vestibular migraine according to the vestibular function test results. Korean J Audiol. 2013;17(1):18–22.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Thomas Jefferson University, 900 Walnut St Suite 200, Philadelphia, PA, 19107, USA

    Clinton G. Lauritsen DO & Michael J. Marmura MD

Authors
  1. Clinton G. Lauritsen DO
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Marmura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clinton G. Lauritsen DO.

Ethics declarations

Conflict of Interest

Clinton G. Lauritsen has received honoraria from Cefaly Technology. Michael J. Marmura has received royalty payments from Cambridge, Devos Medical, and Medlink Neurology; salary support from Teva; and received compensation for consultations from Supernus.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Neurologic Ophthalmology and Otology

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lauritsen, C.G., Marmura, M.J. Current Treatment Options: Vestibular Migraine. Curr Treat Options Neurol 19, 38 (2017). https://doi.org/10.1007/s11940-017-0476-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11940-017-0476-z

Keywords

search

Navigation